| Tag | Content |
|---|
EnhancerAtlas ID | HS130-00175 |
Organism | Homo sapiens |
Tissue/cell | MDA-MB-231 |
Coordinate | chr1:11978590-11979490 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZEB1 | MA0103.3 | chr1:11979373-11979384 | GGGCAGGTGGG | - | 6.14 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_04401 | chr1:11978587-11981573 | Brain_Anterior_Caudate | | SE_05426 | chr1:11978434-11981619 | Brain_Cingulate_Gyrus | | SE_06308 | chr1:11978399-11981725 | Brain_Hippocampus_Middle | | SE_07453 | chr1:11978787-11981538 | Brain_Hippocampus_Middle_150 | | SE_08423 | chr1:11977980-11981628 | Brain_Inferior_Temporal_Lobe |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I011918 | chr1 | 11978644 | 11979927 |
|
Enhancer Sequence | CACCCTCCCG AGTAGCTGGG ATTACAGGCA TGCACCACCA CGCCTGGATA ATTTTGTATT 60
TTTAGTGGAG ATGGGGTTTC TCCATCTTGG TCAGGCTGGT CTTGAACTCC CGCCCTCTGG 120
TGATCTGCTC ACCTCAGCCT CCCAAAGTGT TGGGATTACA GGCGTGAGCC ACCACGCCCG 180
GTCTTGTTTT ACATTTATGG GAGCCTACAA CATGCCCAGT TCCAAGTTCA AGAAGGAATG 240
GGAGCTGCAG TTGTTGTGGT CTAACAGCTT TCCGTTTAAT GTCACACTGT AAATGACACC 300
AATTGCACCC CAGGAGGTTC CCACTCTGTA ATAGGTGAAC CAGCCCGTGG CCCACGGCTG 360
GAAGATCACA TGTCAGAGCT CTGCATGAGC CAGGGGAGAA GGTGCTGCAT GGACAGAAGT 420
AAGTGGGTGA CCAGTGCCAC TAAAAGCAGA GCTTGAGTTT ACTCTCATAA CCATCGGCTG 480
TGGGCCAGAC ATTTGGCTGC TTTGCAGGCA GACCAGGCTT CCCGGTGAGT CATGCTGCTT 540
AAAATGCTGT CTGGGAACGC AGAGAAAGTC TAAACGCCAA GACGCTGAGG ACAGCCCCGC 600
AGGTGGACTG CCATGCCCGG CTCGGCCCCT TTTTGGTCCC CAGAGTGGAC CCTTCTCCTC 660
CCCACAGAGG GGAGGCATCT GATGGTGGCT TCAGCAGACA ACCTGGAGAA GAACCACTCA 720
GGGTTTGTCT TGCTGACGTC CTATAGCCAG CAAAACCCAG GGCAGGAGAA CCCTGGCTCT 780
TTAGGGCAGG TGGGGGAGAG GGCATCTTAG CAGGGAAGGA GCTAGGGTAA TGCCAGAAGC 840
AACCCACTCA GCAGGGCCAC TCAGCAACCC CCTGGCGAGC AGAAAGGTGG CAAACAACAC 900
|
